Mark Hull Selected Research

Interferon Lambda

1/2017	A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.
3/2015	Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Hull Research Topics

Disease

12	Coinfection 01/2023 - 01/2013
11	COVID-19 12/2023 - 10/2021
10	Infections 10/2023 - 01/2013
8	Hepatitis C 01/2019 - 07/2014
4	HIV Infections (HIV Infection) 02/2022 - 01/2016
4	Fibrosis (Cirrhosis) 01/2021 - 01/2015
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 01/2016
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 12/2014
3	Reinfection 10/2023 - 01/2015
3	Chronic Renal Insufficiency 01/2018 - 01/2016
3	End Stage Liver Disease 01/2017 - 01/2016
2	Syphilis 05/2024 - 01/2020
2	Viremia 01/2023 - 01/2022
2	Substance-Related Disorders (Drug Abuse) 12/2021 - 05/2015
2	Obesity 01/2020 - 10/2016
2	Chronic Hepatitis B 01/2017 - 01/2016
2	Liver Diseases (Liver Disease) 11/2014 - 01/2013
1	Gonorrhea 01/2022
1	Binge Drinking 01/2021
1	Diabetes Mellitus 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Hepatitis 11/2016
1	Crohn Disease (Crohn's Disease) 10/2016
1	Necrosis 10/2016
1	Lung Neoplasms (Lung Cancer) 02/2013

Drug/Important Bio-Agent (IBA)

12	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2013
7	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2013
6	VaccinesIBA 12/2023 - 10/2021
6	InterferonsIBA 01/2023 - 07/2014
3	Ribavirin (Virazole)FDA LinkGeneric 01/2021 - 07/2014
3	SimeprevirIBA 04/2016 - 11/2014
3	SofosbuvirIBA 04/2016 - 11/2014
2	Doxycycline (Periostat)FDA LinkGeneric 05/2024 - 01/2020
2	trans-crotonin (CTN)IBA 10/2023 - 12/2021
2	N-(2-cyanoethylene)urea (BA 1)IBA 10/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
2	Tenofovir (Viread)FDA Link 01/2023 - 01/2016
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022 - 12/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2016
2	Interferon LambdaIBA 01/2017 - 03/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 11/2014
1	Messenger RNA (mRNA)IBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	entecavir FDA Link 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Cocaine (Cocaine HCl)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Lipopolysaccharide ReceptorsIBA 01/2017
1	Chemokine CCL5IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Infliximab (Remicade)FDA Link 10/2016
1	AntibodiesIBA 10/2016
1	sofosbuvir drug combination ledipasvirIBA 04/2016
1	Ritonavir (Norvir)FDA Link 04/2016
1	dasabuvirIBA 04/2016
1	ombitasvirIBA 04/2016
1	paritaprevirIBA 04/2016
1	daclatasvirIBA 04/2016
1	Emtricitabine (Emtriva)FDA Link 01/2016
1	lamivudine drug combination abacavir FDA Link 01/2016
1	RacivirIBA 01/2016
1	Reverse Transcriptase InhibitorsIBA 01/2016
1	Aspartic Acid (Aspartate)FDA Link 01/2016
1	TransferasesIBA 01/2016
1	Citalopram FDA LinkGeneric 07/2014
1	SmokeIBA 02/2013

Therapy/Procedure

18	Therapeutics 12/2023 - 01/2013
4	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 01/2016
2	Art Therapy 01/2023 - 12/2014
1	Retreatment 10/2023
1	Condoms (Condom) 01/2022
1	Continuity of Patient Care 01/2022
1	Bariatric Surgery 01/2020
1	Secondary Prevention 11/2016
1	Liver Transplantation 01/2016
1	Aftercare (After-Treatment) 05/2015